Glen Ellyn, IL, United States of America

Heidie M Jevey

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Dow Global Technolgoies LLC. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heidie M Jevey. Retrieved from https://idiyas.com/inventor/heidie-m-jevey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Heidie M Jevey: Innovator in Biocidal Compositions

Introduction

Heidie M Jevey is a notable inventor based in Glen Ellyn, Illinois. She has made significant contributions to the field of biocidal compositions, showcasing her expertise and innovative spirit.

Latest Patents

Heidie holds a patent for biocidal compositions that include 1-(3-chloroallyl)-3,5,7-triaza-1-azonia-adamantane chloride, along with an optional second biocide. These compositions are formulated in copolymers of ethylene oxide and propylene oxide, demonstrating excellent color and phase stability.

Career Highlights

Heidie is associated with Dow Global Technologies LLC, where she applies her knowledge and skills to advance the development of effective biocidal products. Her work has been instrumental in enhancing the stability and efficacy of these compositions.

Collaborations

Heidie collaborates with talented coworkers, including Ioana Annis and Suzanne DeBruhl, contributing to a dynamic and innovative work environment.

Conclusion

Heidie M Jevey's contributions to biocidal compositions reflect her dedication to innovation and excellence in her field. Her work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…